Emerson Process Management Continues Life Sciences Growth in Asia-Pacific

AUSTIN, Texas–Emerson Process Management, a global process control and automation leader and a business of Emerson (NYSE:EMR), has been selected by Switzerland-based Lonza Group Ltd. to provide engineering and design services and digital automation architecture and control technologies for a new Lonza biopharmaceutical plant in Singapore.

The win is part of Emerson’s growing portfolio of life sciences companies that rely on digital automation with predictive intelligence to reduce overall costs, improve reliability, ensure product quality, meet regulatory requirements, and optimize operations.

“Emerson has an excellent track record in managing and controlling the highly complex processes involved in the biopharmaceutical industry,” said Steve Sonnenberg, president, Emerson Process Management. “This win is yet another example of how companies like Lonza can leverage our global resources and expertise to meet their objectives for safe, reliable, and on-time start-up of new manufacturing facilities.”

In the Asia-Pacific region, Emerson also has been awarded automation contracts by Shanghai CP Guojian Pharmaceutical Co. Ltd. in China; Reliance Life Sciences, DSM Anti-Infectives India Ltd., and Biocon in India; and Lonza for a prior facility in Singapore.

Having installed the automation architecture in Lonza’s first biopharmaceutical plant in Singapore, Emerson was chosen to implement its innovative PlantWeb® technologies in the new plant that is expected to be completed in 2010 at a cost of US$350 million. By following the original project models, employing best practices, and applying the experience gained during design and construction of the original facility, Emerson is expected to reduce Lonza’s overall costs for the new plant.

Lonza will employ an array of Emerson products and services, including: PlantWeb digital automation architecture; DeltaV™ digital automation system; and intelligent digital devices, including Fisher® and Baumann™ control valves with FIELDVUE® digital valve controllers, Rosemount® flowmeters and analyzers, Micro Motion® Coriolis flowmeters, and Fisher pressure regulators.

About Lonza

Lonza is the world’s leading contract manufacturer of monoclonal antibodies and recombinant proteins. Lonza undertakes highly specialized development and manufacturing services for the pharmaceutical and biotechnology industries based on more than 25 years of experience in mammalian cell culture and proprietary technology for large-scale manufacture of innovative biopharmaceutical products. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza Group Ltd. is headquartered in Basel, Switzerland, and is listed on the SWX Swiss Stock Exchange.

About Emerson Process Management

Emerson Process Management (www.emersonprocess.com), an Emerson business, is a leader in helping businesses automate their production, processing and distribution in the chemical, oil and gas, refining, pulp and paper, power, water and wastewater treatment, mining and metals, food and beverage, pharmaceutical and other industries. The company combines superior products and technology with industry-specific engineering, consulting, project management and maintenance services. Its brands include PlantWeb®, Fisher®, Rosemount®, Micro Motion®, Daniel®, DeltaV™, Ovation®, and AMS® Suite.

About Emerson

Emerson (NYSE:EMR), based in St. Louis, Missouri (USA), is a global leader in bringing technology and engineering together to provide innovative solutions to customers through its network power, process management, industrial automation, climate technologies, and appliance and tools businesses. Sales in fiscal 2008 were $24.8 billion and Emerson is ranked 94th on the Fortune 500 list of America’s largest companies. For more information, visit www.Emerson.com.